Factory Supply High Quality Emtricitabine powder CAS 143491-57-0

Min.Order / FOB Price:Get Latest Price

1 Kilogram	FOB Price: USD 350.0000

1 Kilogram

FOB Price: USD 350.0000

Min.Order :1 Kilogram
Purity: 99%
Payment Terms : L/C,D/A,D/P,T/T,,MoneyGram

Keywords

Emtricitabine Emtricitabine powder High Quality Emtricitrabine

Quick Details

Appearance:white powder
Application:antiviral
PackAge:25KG/drum or as your requirement
ProductionCapacity:100|Metric Ton|Year
Storage:Room temperature
Transportation:Room Temperature

Superiority:

Why is SINOWAY:

1) Specialized in pharmaceutical and healthcare industrial for 34 years.

2) ISO 9001:2015 & SGS audited supplier .

3) Accept various payment terms : T.T 30-60 days.

4) We have warehouse in USA with quickly shipment .

5) We can do different terms of FOB ,CIF/CIP ,DDP ...

Our Advantange of Emtritabine:

1. Quality: 99% up by HPLC, full test report.

2. Documents: DMF, our facotory pass FDA audit with Zero defect. passing MCC in South African,
3. Large capacity & stock :80MT per year with 1000kg in stock for prompt shipment
4. Better payment terms : We can make use of Export Credit Insurance after confirming yr credit report accepted by Sinosure, accept Alibaba Trade Assurance
5. Various shipping ways for your choice : by air./ by sea / by courier (DHL/FedEx).

6. we also provide TDF, Efavirenz, that used togher with Emtritabine as the Compound Preparation to treat HIV.

the main Compound Preparation:

TDF+Emtricitabine and TDF+Emtricitabine+Efavirenz.

Details:

the information of Emtritabine:

Product name	Emtricitabine
CAS No.	143491-57-0
Molecular Formula	C8H10FN3O3S
Molecular Weight	247.247
Quality Standard	98% up, Medicine Grade
Appearance	White powder

2. The COA of Emtritabine

The use of Emtritabine:

Emtricitabine is a new type of nucleoside reverse transcriptase inhibitor that has antiviral activity against HIV-1, HIV-2 and HBV. This product is phosphorylated into cellular active 5'-triphosphate after oral administration. The 5'-triphosphate enters the viral DNA backbone and binds to the backbone, resulting in chain termination, thereby inhibiting HIV-1 reverse transcriptase and HBV DNA polymerase activity.

Emtricitabine does not affect the liver microsomal enzyme P450 enzyme system, and does not produce drug interactions mediated by it. It is used in combination with tenofovir, indinavir, famciclovir, and stanvudine, with almost no pharmacokinetics influences.